CL
STAA icon

CRCM LP’s STAAR Surgical STAA Stock Holding History

CRCM LP’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,000
Closed -$1.87M – 15
2026
Q1 		$1.87M Buy
+100,000
New +$1.91M 1.32% 5

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CRCM LP's STAA Position: Q2 2026 in Review

CRCM LP sold out of STAAR Surgical (STAA) in Q2 2026, closing a stake of 100,000 shares — an estimated $1.87M sold.

CRCM LP first reported a position in STAA in Q1 2026 and held it in 1 quarter. The position peaked at $1.87M in Q1 2026. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • CRCM LP reported no remaining STAAR Surgical position as of Q2 2026 after selling out during the quarter.
  • CRCM LP sold 100,000 STAAR Surgical shares in Q2 2026, an estimated $1.87M.
  • CRCM LP first reported a position in STAAR Surgical in Q1 2026 and held it in 1 quarter.
  • CRCM LP's STAAR Surgical position peaked at $1.87M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on CRCM LP's 13F filing for Q2 2026, filed 12 Aug 2026.